InflammagingReview

Beyond Lipid Lowering: A Narrative Review and Expert Perspective on Precision Cardiovascular Prevention in People with HIV After REPRIEVE

Figure 1. Mechanistic hierarchy of HIV-associated atherosclerosis and residual cardiovascular risk.
Open the figure at full size
Figure 1. Mechanistic hierarchy of HIV-associated atherosclerosis and residual cardiovascular risk.Mechanistic hierarchy of HIV-associated atherosclerosis and residual cardiovascular risk.Domingo et al. · CC BY

Biomolecules

Abstract

The spectrum of diseases in individuals with human immunodeficiency virus (HIV) receiving successful antiretroviral therapy has evolved over time. In the past, they developed opportunistic infections and malignancies, whereas today, cardiovascular disease is among the most common causes of illness and premature death.

The paper

Universitat Autònoma de Barcelona

Biomolecules · 29 Aug 2026 · CC BY

doi.org/10.3390/biom16091254PubMed 42793086

More on Cardiovascular disease